Molecular Omics

期刊简介：Molecular Omics publishes high-quality research from across the -omics sciences.Topics include, but are not limited to: -omics studies to gain mechanistic insight into biological processes – for example, determining the mode of action of a drug or the basis of a particular phenotype, such as drought tolerance -omics studies for clinical applications with validation, such as finding biomarkers for diagnostics or potential new drug targets -omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques -studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques. New methods should be proven and demonstrate an advance in the field. Molecular Omics only accepts articles of high importance and interest that provide significant new insight into important chemical or biological problems. This could be fundamental research that significantly increases understanding or research that demonstrates clear functional benefits. Papers reporting new results that could be routinely predicted, do not show a significant improvement over known research, or are of interest only to the specialist in the area are not suitable for publication in Molecular Omics.

【译文】Molecular Omics 发表来自全-omics 科学领域的高质量研究。主题包括但不限于：通过-omics 研究，深入了解生物过程——例如，确定药物的作用方式或特定表型的基础，如耐旱性；具有验证的-omics 研究临床应用，如寻找诊断生物标志物或潜在的新药靶点；研究细胞的亚细胞组成——例如，某些蛋白质的亚细胞定位或翻译后修饰或新的成像技术；展示支持-omics 研究的新方法和新工具的研究，包括新的光谱/色谱技术、基于芯片/阵列技术以及新的分类/数据分析技术。新方法应得到证明并展示在领域内的进步。Molecular Omics 仅接受具有重要性和兴趣的文章，这些文章对重要的化学或生物学问题提供了重大的新见解。这可能包括显著增加理解的基础研究，或展示明确功能益处的研究。报告新结果的文章，如果可以常规预测，没有在已知研究上显示出显著的改进，或仅对领域专家感兴趣，则不适合在 Molecular Omics 发表。